Latest Content

Nicole Schulz was 14 when she received an AML diagnosis. She shares what carried her through two transplants and 11 months in the hospital.

Adding sirexatamab did not delay cancer growth overall, but patients with higher levels of a blood protein called DKK1 went longer without their cancer worsening.

Laura Yeager reflects on attending a Bridgerton-themed gala as a flat-chested breast cancer survivor, finding humor and freedom in a room full of corsets and cleavage.

A multiple myeloma survivor and advocate answers the questions people ask most after a diagnosis, from maintenance therapy to stem cell transplant.

Weekly smartphone check-ins that alerted the care team when symptoms worsened and improved physical functioning at six months.

Divesiran met the primary end point of the phase 2 SANRECO trial, with 88% of patients avoiding phlebotomy and keeping hematocrit below 45%, according to new trial results.

Doctors say patients with cancer face distinct risks during the cyclosporiasis outbreak that spans 45 states.

After moving two hours away, a survivor weighs staying with the cancer center that knows her history against finding an oncologist close to home.

Sanita Burgic, of Washington University Siteman Cancer Center, combines clinical excellence and deep empathy to support cancer patients and elevate her entire oncology team.

Lung cancer advocate Katie shares how losing her father to the disease and her own cancer journey inspire her work with LiveLung today.

Multiple myeloma and breast cancer survivor Valerie Traynham shares why survivorship begins at diagnosis and offers hope, resilience and life after cancer insights.

An oncologist explains why the choice between removing one lobe or the whole thyroid should be a conversation, not a surprise.

Noreen Walsh, RN, MSN, OCN, of St. Francis Hospital and Cancer Institute, builds deep personal bonds with cancer patients and families that extend far beyond clinical care.